Jo Bhakdi is the founder and CEO of Quantgene. His work in machine learning, sequencing technology and DNA extraction procedures defines the cutting edge of genomic diagnostics, early disease detection and precision medicine.
Prior to Quantgene, Jo founded i2X, an investment framework that composes low-risk Venture Capital portfolios across large numbers of technology startups. The i2X platform laid important foundations for advanced analytics in both financial and biotechnology applications, such as the Quantgene machine learning platform.
Bhakdi holds a Masters in Economics and Psychology from Tubingen University, one of Germany’s leading academic institutions, with a focus on financial theory and statistics. He started his career at WPP and Omnicom where he held Strategy and Executive Director positions.
Beyond his focus on technology and the future of medicine, Bhakdi is dedicated to bringing the brightest, pioneering minds together, to push the boundaries of health, life and innovation for all.